BSN Capital Partners’s iShares China Large-Cap ETF FXI Stock Holding History

BSN Capital Partners’s Portfolio FXI Stock Details FXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,450,107	Closed	-$40.5M	–	10
2022 Q4	$40.5M	Sell	1,450,107 -7,049,893	-83%	-$182M	2.87%	11
2022 Q3	$231M	Buy	+8,500,000	New	+$255M	53.91%	1

Other funds holding FXI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BSN Capital Partners's FXI Position: Q1 2023 in Review

BSN Capital Partners sold out of iShares China Large-Cap ETF (FXI) in Q1 2023, closing a stake of 1,450,107 shares — an estimated $40.5M sold.

BSN Capital Partners first reported a position in FXI in Q3 2022 and held it in 2 quarters. The position peaked at $231M in Q3 2022. 258 funds tracked by Wall St. Rank hold FXI as of Q1 2023.

BSN Capital Partners reported no remaining iShares China Large-Cap ETF position as of Q1 2023 after selling out during the quarter.
BSN Capital Partners sold 1,450,107 iShares China Large-Cap ETF shares in Q1 2023, an estimated $40.5M.
BSN Capital Partners first reported a position in iShares China Large-Cap ETF in Q3 2022 and held it in 2 quarters.
BSN Capital Partners's iShares China Large-Cap ETF position peaked at $231M in Q3 2022.
258 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q1 2023.

Based on BSN Capital Partners's 13F filing for Q1 2023, filed 20 Apr 2023.